SEC Form 4 · accession 0001209191-15-004054
SOLENO THERAPEUTICS INC · SLNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
W James Alexander
Director · 10% Owner
Period of report
Jan 11, 2015
Accepted (ET)
Jan 13, 2015 · 9:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001484565
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock OptionF1 | $1.80 | Jan 11, 2015 | A | 5,000 | A | Jan 11, 2016 | Jan 11, 2025 | Common Stock | 5,000 | 5,000 | D |
Explanation of responses
- F1Beginning on January 11, 2016, twenty-five percent (25%) of the shares subject to the Option shall vest immediately and additional twenty-five percent (25%) of the total shares subject to the Option shall vest annually thereafter on the same day of the month as the date of grant, subject to Optionee's continuing to be a Service Provider on such dates.